Gufic Biosciences Limited (NSE:GUFICBIO)

Gufic Biosciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 16, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	38,120	28,394	18,095	24,129	8,896	3,670
Market Cap Growth	44.52%	56.92%	-25.01%	171.24%	142.42%	-38.00%
Enterprise Value	40,886	31,818	19,487	23,753	10,059	4,721
Last Close Price	379.75	282.43	186.29	248.73	114.32	47.75
PE Ratio	46.50	32.96	22.70	25.18	20.11	16.18
PS Ratio	4.71	3.52	2.62	3.10	1.82	0.97
PB Ratio	6.64	5.33	5.20	8.97	5.13	2.84
P/TBV Ratio	6.71	5.39	5.21	8.99	5.14	2.85
P/FCF Ratio	-	-	-	128.44	11.89	50.60
P/OCF Ratio	-	-	-	22.71	10.20	7.79
EV/Sales Ratio	5.05	3.94	2.82	3.05	2.06	1.25
EV/EBITDA Ratio	29.26	22.60	14.91	16.61	12.51	9.56
EV/EBIT Ratio	32.12	24.26	16.90	18.40	14.87	12.25
EV/FCF Ratio	-	-	-	126.44	13.44	65.10
Debt / Equity Ratio	0.52	0.63	0.96	0.24	0.36	0.98
Debt / EBITDA Ratio	2.12	2.25	2.43	0.44	0.73	2.41
Debt / FCF Ratio	-	-	-	3.43	0.82	17.43
Asset Turnover	-	0.83	1.00	1.71	1.22	1.10
Inventory Turnover	-	2.08	2.27	4.01	2.37	1.71
Quick Ratio	-	0.89	0.81	0.88	0.80	0.46
Current Ratio	-	1.61	1.61	1.72	1.59	1.14
Return on Equity (ROE)	-	19.57%	25.84%	43.31%	29.22%	22.17%
Return on Assets (ROA)	-	8.39%	10.43%	17.67%	10.58%	7.01%
Return on Capital (ROIC)	9.82%	10.59%	14.20%	28.39%	17.23%	11.23%
Return on Capital Employed (ROCE)	-	18.20%	20.10%	38.50%	29.60%	23.00%
Earnings Yield	2.15%	3.03%	4.41%	3.97%	4.97%	6.18%
FCF Yield	-	-4.23%	-11.84%	0.78%	8.41%	1.98%
Dividend Yield	0.03%	0.03%	0.05%	0.04%	0.09%	0.10%
Payout Ratio	-	1.13%	1.31%	0.96%	0.82%	2.15%
Buyback Yield / Dilution	-2.69%	-1.63%	-	-	-24.56%	-
Total Shareholder Return	-2.66%	-1.59%	0.05%	0.04%	-24.47%	0.10%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.